cyc 202 has been researched along with Pleurisy in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brady, HJ; Caldicott, A; Crescenzi, E; Dransfield, I; Duffin, R; Gray, M; Haslett, C; Martin, MC; Martinez-Losa, M; Riley, NA; Rossi, AG; Savill, JS; Sawatzky, DA; Sheldrake, TA; Walker, A; Walker, TR; Ward, C | 1 |
1 other study(ies) available for cyc 202 and Pleurisy
Article | Year |
---|---|
Cyclin-dependent kinase inhibitors enhance the resolution of inflammation by promoting inflammatory cell apoptosis.
Topics: Amino Acid Chloromethyl Ketones; Animals; Apoptosis; Azepines; Carrageenan; Caspase 3; Cyclin-Dependent Kinases; Enzyme Inhibitors; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Inflammation; Male; Mice; Myeloid Cell Leukemia Sequence 1 Protein; Neoplasm Proteins; Neutrophils; Pleurisy; Proto-Oncogene Proteins c-bcl-2; Purines; Pyrroles; Roscovitine | 2006 |